Nektar Therapeutics (NKTR) Insider Trading & Ownership

$1.30

+0.03 (+2.36%)

(As of 09/20/2024 ET)

Current Insider Ownership Percentage: 3.71%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 4
Amount Of Insider Selling (Last 12 Months): $227,143.14

Get NKTR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nektar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NKTR Insider Buying and Selling by Quarter

Ad Porter & Company

Trump’s weapon lurks in abandoned America

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

Go here now to watch my new documentary

Nektar Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/19/2024	Howard W Robin	CEO	Sell	14,881	$1.28	$19,047.68
8/19/2024	Jonathan Zalevsky	Insider	Sell	6,866	$1.28	$8,788.48
6/14/2024	Robert Chess	Director	Sell	19,500	$1.20	$23,400.00
5/17/2024	Howard W Robin	CEO	Sell	16,650	$1.75	$29,137.50
5/17/2024	Jonathan Zalevsky	Insider	Sell	7,355	$1.75	$12,871.25
5/10/2024	Deep Track Capital, Lp	Major Shareholder	Sell	56,000	$1.78	$99,680.00
Our #1 Ticker for the Rare "Retirement Window" (Ad) We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires. Click here for our #1 "Retirement Window" Stock >>>
2/20/2024	Howard W Robin	CEO	Sell	20,033	$0.68	$13,622.44
2/20/2024	Jonathan Zalevsky	Insider	Sell	9,014	$0.68	$6,129.52
11/17/2023	Howard W Robin	CEO	Sell	19,877	$0.49	$9,739.73
11/17/2023	Jonathan Zalevsky	Insider	Sell	9,646	$0.49	$4,726.54

(Data available from 1/1/2013 forward)

NKTR Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Nektar Therapeutics includes Deep Track Capital, Lp, Gil M Labrucherie, Howard W Robin, Jillian B Thomsen, John Northcott, Jonathan Zalevsky, Karin Eastham, Mark Andrew Wilson, Myriam Curet, Robert Chess, and Roy A Whitfield. Learn more on insiders at NKTR.
: 3.71% of Nektar Therapeutics stock is owned by insiders. Learn more on NKTR's insider holdings.
: The following insiders have sold NKTR shares in the last 24 months: Deep Track Capital, Lp ($99,680.00), Howard W Robin ($296,420.69), Jillian B Thomsen ($70,410.15), Jonathan Zalevsky ($126,637.85), Myriam Curet ($16,273.39), Robert Chess ($23,400.00), and Roy A Whitfield ($17,100.00).
: Insiders have sold a total of 381,187 Nektar Therapeutics shares in the last 24 months for a total of $649,922.08 sold.

Nektar Therapeutics Key Executives

Mr. Howard W. Robin (Age 71)
CEO, President & Director
Compensation: $1.83M
2 recent trades
Mr. Mark A. Wilson (Age 52)
Senior VP, Chief Legal Officer & Secretary
Compensation: $749.99k
Dr. Jonathan Zalevsky Ph.D. (Age 49)
Chief Research & Development Officer
Compensation: $1.25M
Ms. Sandra A. Gardiner (Age 58)
Interim Chief Financial Officer
Vivian Wu
Director of Investor Relations & Corporate Affairs
Mr. Robert Bacci
Senior Vice President of Human Resources & Facilities Operations
Ms. Jennifer Ruddock
Chief Business Officer
Dr. Mary Tagliaferri L.Ac. (Age 58)
M.D., Chief Medical Officer